COVID-19 Vaccine Linked to Exacerbation of Graves Disease
Investigators report on a case series of patients who experienced new onset or relapsed Graves disease-related hyperthyroidism following undergoing vaccination for COVID-19.
Investigators report on a case series of patients who experienced new onset or relapsed Graves disease-related hyperthyroidism following undergoing vaccination for COVID-19.
While rare, pediatric Graves disease is on the rise. Medical professionals across several disciplines reviewed current medical literature to provide the most up-to-date information on the disease.
A relationship between thyroid dysfunction, autoimmune thyroid disorders, and COVID-19 infection is evolving in medical literature. Researchers investigated whether this link extended to the COVID-19 vaccine.
Diabetes and thyroid disease often coexist in patients with the disorders, but the connection between new onset diabetes with thyroid dysfunction is unclear. Investigators looked for the link.
Graves disease can alter the medial temporal lobe. Researchers sought to observe whether therapeutic interventions could restore normal brain structure.
Graves hyperthyroidism has a remission rate of 20%-30% with standard antithyroid drug treatment, but long-term use can be problematic. Researchers explored whether adjuvant rituximab would aid remission rates.
The researchers sought to determine the clinical and biochemical features of alemtuzumab-induced autoimmune thyroid events and look their risk factors with a focus on fluctuating Graves’ disease.
Vitamin D deficiency has been diagnosed in an estimated 1 billion people worldwide. An essential fat-soluble nutrient with hormone like-activity, researchers sought to discover whether there was a link between low vitamin D levels and thyroid disorders.
Researchers examined the relationship of radiaoactive iodine treatment on antithyroid antibody levels and a potential link between these levels and radioiodine uptake in people with Graves disease.
Investigators assessed the relationship between intraoperative measurements obtained via laser speckle contrast imaging and outcomes following total thyroidectomy.